Corvus Pharmaceuticals In... (CRVS)

3.17

-0.01 (-0.31%)

At close: Apr 01, 2025, 3:59 PM

3.22

1.70%

After-hours: Apr 01, 2025, 07:55 PM EDT

Corvus Pharmaceuticals Cash Flow Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Net Income	-62.29M	-27.03M	-41.31M	-43.24M	-6M
Depreciation & Amortization	85K	151K	367K	460K	632K
Stock-Based Compensation	3M	2.15M	2.69M	4.23M	5.75M
Other Working Capital	n/a	-3.71M	1.08M	-827K	890K
Other Non-Cash Items	33.78M	4.39M	9.81M	5.07M	-37.07M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	-3.59M	1.41M	-3.24M	1.91M
Operating Cash Flow	-25.42M	-23.93M	-27.02M	-36.72M	-34.78M
Capital Expenditures	n/a	-34K	-269K	-5K	-76K
Acquisitions	n/a	n/a	22K	-21.57K	-44.84K
Purchase of Investments	-70.12M	-47.05M	-66.19M	-9.36M	-42.54M
Sales Maturities Of Investments	42.63M	62.62M	43.16M	30.92M	87.39M
Other Investing Acitivies	5K	n/a	-23.01K	21.57K	44.84K
Investing Cash Flow	-27.48M	15.54M	-23.28M	21.56M	44.77M
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	32.62M	12K	n/a	1.22M	88K
Financial Cash Flow	49.03M	7.86M	n/a	62.16M	1.31M
Net Cash Flow	-3.88M	-539K	-50.3M	47M	11.3M
Free Cash Flow	-25.42M	-23.97M	-27.29M	-36.72M	-34.85M